AKT1 and neoplasm: To further identify that circSEMA4B functions as a tumor suppressor mainly through PI3K/Akt pathway, we exploit whether Akt inhibitor MK2206 recapitulates the effect of circSEMA4B overexpression in repressing the malignant phenotypes of BC cells.